US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Pain Aid Esf-

Reason CGMP Deviations: failed stability results, inadequate laboratory investigations,

ULTRAtab Laboratories, Inc. NDC 62959-560-00 D-0327-2022
Class II · Moderate risk Terminated

Moxifloxacin

Reason Labeling: Label Mix-up: Vials labeled as moxifloxacin 1 mg/mL may actually contain moxifloxacin 5 mg/mL

Denver Solutions, LLC DBA Leiters Health NDC 71449-096-42 D-0288-2022
Class II · Moderate risk Ongoing

Diclofenac Sodium Topical Solution

Reason Defective container: Out of specification for container integrity leading to bottles leaking.

Preferred Pharmaceuticals, Inc. NDC 68788-7707-01 D-0278-2022
Class II · Moderate risk Terminated

Secret Dry Spray

Reason CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene

The Procter & Gamble Company D-0256-2024
Class II · Moderate risk Terminated

Secret

Reason CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene

The Procter & Gamble Company D-0255-2024
Class II · Moderate risk Terminated

Secret

Reason CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene

The Procter & Gamble Company D-0254-2024
Class II · Moderate risk Terminated

Secret

Reason CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene

The Procter & Gamble Company NDC 37000-134-11 D-0253-2024
Class II · Moderate risk Terminated

Old Spice

Reason CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene

The Procter & Gamble Company D-0252-2024
Class II · Moderate risk Terminated

Old Spice

Reason CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene

The Procter & Gamble Company D-0251-2024
Class II · Moderate risk Terminated

Old Spice

Reason CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene

The Procter & Gamble Company D-0250-2024
Class II · Moderate risk Terminated

Old Spice Pure Sport 2021 Gift Set

Reason CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene

The Procter & Gamble Company NDC 69423-590-01 D-0249-2024
Class II · Moderate risk Terminated

Secret OUTLAST Dry Spray

Reason CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene

The Procter & Gamble Company D-0248-2024
Class II · Moderate risk Terminated

Secret

Reason CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene

The Procter & Gamble Company D-0247-2024
Class II · Moderate risk Terminated

Secret

Reason CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene

The Procter & Gamble Company D-0245-2024
Class II · Moderate risk Terminated

Old Spice

Reason CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene

The Procter & Gamble Company NDC 69423-386-10 D-0239-2024
Class II · Moderate risk Terminated

Biotin Solution for Injection

Reason Lack of Assurance of Sterility

Asp Cares NDC 72833-0589-30 D-0261-2022
Class II · Moderate risk Terminated

PHENYLephrine HCl

Reason Lack of Assurance of Sterility

SterRx, LLC NDC 70324-901-01 D-0324-2022
Class II · Moderate risk Terminated

PHENYLephrine HCl

Reason Lack of Assurance of Sterility

SterRx, LLC NDC 70324-252-01 D-0323-2022
Class II · Moderate risk Terminated

Norepinephrine

Reason Lack of Assurance of Sterility

SterRx, LLC NDC 70324-926-01 D-0322-2022
Class II · Moderate risk Terminated

Norepinephrine

Reason Lack of Assurance of Sterility

SterRx, LLC NDC 70324-676-01 D-0321-2022
Class II · Moderate risk Terminated

Norepinephrine

Reason Lack of Assurance of Sterility

SterRx, LLC NDC 70324-651-01 D-0320-2022